|
1
|
Zaman A, Capper R and Baddoo W:
Waardenburg syndrome: More common than you think! Clin Otolaryngol.
40:44–48. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Read AP and Newton VE: Waardenburg
syndrome. J Med Genet. 34:656–665. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baxter LL, Hou L, Loftus SK and Pavan WJ:
Spotlight on spotted mice: A review of white spotting mouse mutants
and associated human pigmentation disorders. Pigment Cell Res.
17:215–224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mollaaghababa R and Pavan WJ: The
importance of having your SOX on: Role of SOX10 in the development
of neural crest-derived melanocytes and glia. Oncogene.
22:3024–3034. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pingault V, Ente D, Dastot-Le Moal F,
Goossens M, Marlin S and Bondurand N: Review and update of
mutations causing Waardenburg syndrome. Hum Mutat. 31:391–406.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Song J, Feng Y, Acke FR, Coucke P,
Vleminckx K and Dhooge IJ: Hearing loss in Waardenburg syndrome: A
systematic review. Clin Genet. Jun 22–2016.(Epub ahead of print).
View Article : Google Scholar
|
|
7
|
DeStefano AL, Cupples LA, Arnos KS, Asher
JH Jr, Baldwin CT, Blanton S, Carey ML, da Silva EO, Friedman TB,
Greenberg J, et al: Correlation on between Waardenburg syndrome
phenotype and genotype in a population of individuals with
identified PAX3 mutations. Hum Genet. 102:499–506. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tassabehji M, Newton VE, Liu XZ, Brady A,
Donnai DK, ajewska-Walasek M, Murday V, Norman A, Obersztyn E,
Reardon W, et al: The mutational spectrum in Waardenburg syndrome.
Hum Mol Genet. 4:2131–2137. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wollnik B, Tukel T, Uyguner O, Ghanbari A,
Kayserili H, Emiroglu M and Yuksel-Apak M: Homozygous and
heterozygous inheritance of PAX3 mutations causes different types
of Waardenburg syndrome. Am J Med Genet A. 122A:42–45. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shibahara S, Takeda K, Yasumoto K, Udono
T, Watanabe K, Saito H and Takahashi K: Microphthalmia-associated
transcription factor (MITF): Multiplicity in structure, function,
and regulation. J Invest Derm Symp Proc. 6:99–104. 2001. View Article : Google Scholar
|
|
11
|
Grill C, Bergsteinsdottir K, Ogmundsdóttir
MH, Pogenberg V, Schepsky A, Wilmanns M, Pingault V and
Steingrimsson E: MITF mutations associated with pigment deficiency
syndromes and melanoma have different effects on protein function.
Hum Mol Genet. 22:357–4367. 2013. View Article : Google Scholar
|
|
12
|
Tassabehji M, Newton VE and Read AP:
Waardenburg syndrome type 2 caused by mutations in the human
microphthalmia (MITF) gene. Nat Genet. 8:251–255. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sánchez-Martín M, Rodríguez-García A,
Pérez-Losada J, Sagrera A, Read AP and Sánchez-García I: SLUG
(SNAI2) deletions in patients with Waardenburg disease. Hum Mol
Genet. 11:3231–3236. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jabeen R, Babar ME, Ahmad J and Awan AR:
Novel mutations of endothelin-B receptor gene in Pakistani patients
with Waardenburg syndrome. Mol Biol Rep. 39:785–788. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Farrer LA, Grundfast KM, Amos J, Arnos KS,
Asher JH Jr, Beighton P, Diehl SR, Fex J, Foy C, Friedman TB, et
al: Waardenburg syndrome (Ws) type-I is caused by defects at
multiple Loci, one of which is near alpp on chromosome-2-1st report
of the Ws consortium. Am J Hum Genet. 50:902–913. 1992.PubMed/NCBI
|
|
16
|
Brenner L, Burke K, Leduc CA, Guha S, Guo
J and Chung WK: Novel splice mutation in microthalmia-associated
transcription factor in Waardenburg Syndrome. Genet Test Mol
Biomarkers. 15:525–529. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen H, Jiang L, Xie Z, Mei L, He C, Hu Z,
Xia K and Feng Y: Novel mutations of PAX3, MITF, and SOX10 genes in
Chinese patients with type I or type II Waardenburg syndrome.
Biochem Biophys Res Commun. 397:70–74. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang L, Chen H, Jiang W, Hu Z, Mei L, Xue
J, He C, Liu Y, Xia K and Feng Y: Novel mutations in the SOX10 gene
in the first two Chinese cases of type IV Waardenburg syndrome.
Biochem Biophys Res Commun. 408:620–624. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang S, Dai P, Liu X, Kang D, Zhang X,
Yang W, Zhou C, Yang S and Yuan H: Genetic and phenotypic
heterogeneity in Chinese patients with Waardenburg syndrome type
II. PLoS One. 8:e771492013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nayak CS and Isaacson G: Worldwide
distribution of Waardenburg syndrome. Ann Oto Rhinol Laryn.
112:817–820. 2003. View Article : Google Scholar
|
|
21
|
Liu X, Newton V and Read A: Hearing loss
and pigmentary disturbances in Waardenburg syndrome with reference
to WS type II. J Laryngol Otol. 109:96–100. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Drozniewska M and Haus O: PAX3 gene
deletion detected by microarray analysis in a girl with hearing
loss. Mol Cytogenet. 7:302014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Berlin I, Denat L, Steunou AL, Puig I,
Champeval D, Colombo S, Roberts K, Bonvin E, Bourgeois Y, Davidson
I, et al: Phosphorylation of BRN2 modulates its interaction with
the Pax3 promoter to control melanocyte migration and
proliferation. Mol Cell Biol. 32:1237–1247. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Degenhardt KR, Milewski RC, Padmanabhan A,
Miller M, Singh MK, Lang D, Engleka KA, Wu ML, Li J, Zhou D, et al:
Distinct enhancers at the Pax3 locus can function redundantly to
regulate neural tube and neural crest expressions. Dev Biol.
339:519–527. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Takeda K, Takemoto C, Kobayashi I,
Watanabe A, Nobukuni Y, Fisher DE and Tachibana M: Ser298 of MITF,
a mutation site in Waardenburg syndrome type 2, is a
phosphorylation site with functional significance. Hum Mol Genet.
9:125–132. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wildhardt G, Zirn B, Graul-Neumann LM,
Wechtenbruch J, Suckfüll M, Buske A, Bohring A, Kubisch C, Vogt S,
Strobl-Wildemann G, et al: Spectrum of novel mutations found in
Waardenburg syndrome types 1 and 2: Implications for molecular
genetic diagnostics. Bmj Open. 3:pii: e001917. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Millan JM, Aller E, Jaijo T, Grau E,
Beneyto M and Najera C: Genetic counselling in visual and auditory
disorders. Arch Soc Esp Oftalmol. 83:689–702. 2008.(In Spanish).
PubMed/NCBI
|
